The <i>CLIP1</i>–<i>LTK</i> fusion: a new oncogenic driver in non-small-cell lung cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The CLIP1–LTK fusion: a new oncogenic driver in non-small-cell lung cancer?

Published:2023-02 Issue:4 Volume:19 Page:273-275
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Ibrahim Rebecca¹,Chahine Claude¹,Felefly Tony²,Khalife Nadine³,Saleh Khalil¹^ORCID

Affiliation:

1. International Department, Gustave Roussy Cancer Campus, Villejuif, 94800, France

2. Radiation Oncology Department, Saint-Joseph University, Beyrouth, 1100, Lebanon

3. Department of Head & Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, 94800, France

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2022-1232

Reference20 articles.

1. Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives

2. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

3. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

4. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

5. Mutations of the BRAF gene in human cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges;Frontiers in Oncology;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP